Briefs

first_imgn Nearly 80% of 17,000 mothers who took part in an FSA online survey supported the Traffic Light Labelling scheme over the rival Guideline Daily Amount labelling scheme preferred by some retailers and manufacturers.n Denver Cottage Bakery of Ilkeston in Derbyshire has been fined more than £1,800 after mouse droppings were found baked onto the outside of a bread roll. The company admitted breaches of hygiene regulations during a hearing before South Derbyshire magistrates after an investigation by health officers found a serious infestation at the bakery. Denver Cottage said it had had no previous problems and that it had now upgraded systems. It was fined £500 with £1,380 costs.n Knaresborough-based marketing company Allott & Associates is offering free advice to the food industry. In a one-off promotion, the agency will conduct a free marketing review to a number of companies. The audit takes about two hours and provides an assessment of a company’s marketing and what steps can be taken to improve it. Call 01423 867 264n A survey by trading standards officers (TSOs) in Herefordshire has shown a drop in the amount of salt being added to bread.The TSOs examined 53 different bread samples from both supermarkets and high street bakers to find an average salt content of 1.2%. This compared to a total of 1.34% in a similar survey in November 2005.n The HGCA’s Innovation is the Key half-day seminar will be held at the British Library Conference Centre in London on 14 March.last_img read more

Vaccine developed against Ebola

first_img Tweet Share Around 1,200 people have died of Ebola virus infection since 1976Scientists have developed a vaccine that protects mice against a deadly form of the Ebola virus. First identified in 1976, Ebola kills more than 90% of the people it infects.The researchers say that this is the first Ebola vaccine to remain viable long-term and can therefore be successfully stockpiled.The results are reported in the journal Proceedings of National Academy of Sciences. Ebola is transmitted via bodily fluids, and can become airborn. Sufferers experience nausea, vomiting, internal bleeding and organ failure before they die.Although few people contract Ebola each year, its effects are so swift and devastating that it is often feared that it could be used against humans in an act of terroism. All previously developed vaccines have relied on injecting intact, but crippled, viral particles into the body.Long-term storage tends to damage the virus, paralysing the vaccine’s effectiveness. The new vaccine contains a synthetic viral protein, which prompts the immune system to better recognise the Ebola virus, and is much more stable when stored long-term. The vaccine protects 80% of the mice injected with the deadly strain, and survives being “dried down and frozen,” said biotechnologist Charles Arntzen from Arizona State University who was involved in its development. He said the next step is to try the vaccine on a strain of Ebola that is closer to the one that infects humans. By Jennifer CarpenterScience reporter, BBC News 8 Views   no discussions Sharecenter_img Share HealthLifestyle Vaccine developed against Ebola by: – December 6, 2011 Sharing is caring!last_img read more

GVC publishes ‘Ladbrokes Coral Prospectus’ confident of delivering a true global player

first_img GVC hires ‘comms pro’ Tessa Curtis to re-energise media profile  August 25, 2020 GVC absorbs retail shocks as business recalibrates for critical H2 trading August 13, 2020 Martin Lycka – Regulatory high temperatures cancel industry’s ‘silly season’ August 11, 2020 Related Articles Share Share StumbleUpon Submit The governance of GVC Holdings has today released its ‘combined prospectus’ relating to its £4 billion takeover deal of Ladbrokes Coral Plc.The deal which enters its final stages has been approved by Ladbrokes Coral governance and is set to be reviewed by the UK Competitions & Markets Authority (CMA), which this week set a 21 February deadline for industry comment.In its investor presentation, GVC governance outlines a ‘highly compelling strategic rationale’ for the enlarged enterprise, which seeks to become the dominant FTSE gambling enterprise.Should the deal be concluded, GVC will move to create a technology leading multi-channel/multi-market gambling group, capable of competing in any jurisdiction through its combined scale and established brands.“The enlarged group will be a fast-growing, diversified, highly profitable, international online and retail sports betting led gaming company with >90% of NGR coming from locally regulated/ taxed markets” details the GVC prospectus.Seeking to deliver fast growth and profits for its investors, GVC states that the new enterprise will set-out to implement the following key enlargement initiatives;Diversified strategy focusing on scale within regulated marketsEstablish leading UK operations with a complementary international revenue base.Creation of a true global gaming & betting enterpriseDeveloping market leading scalable technology systemsClear group focus on sports bettingStrong emphasis on combined synergy creationsFurther deal advantages, see GVC governance highlight the leadership combination of both companies, which have proven executive teams with experience in corporate mergers.Throughout the prospectus, GVC highlights the importance of technology ownership, which the firm believes will help the new FTSE enterprise achieve effective multi-channel distribution combined with ‘highly flexible and highly scalable technology across all verticals’.The combined enterprises of GVC and Ladbrokes Coral will service a total of 15 brands, with an established presence in the UK, Italy, Spain, Belgium, Germany and Australia. Furthermore, the new FTSE gambling enterprise will have a strategical advantage should the US betting market be regulated.In its deal summary, GVC governance urges investors to take ‘the initiative now’, in order to secure ‘strategic and synergy benefits of the combination to be realised in the short term’.As the leading party in the transaction, GVC believes that it has secured stakeholders a flexible deal structure which allows for range of triennial scenarios, combined with favourable financing conditions.last_img read more